BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS, Kim CY. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology. 1996;198:33-40. [PMID: 8539401 DOI: 10.1148/radiology.198.1.8539401] [Cited by in Crossref: 240] [Cited by in F6Publishing: 194] [Article Influence: 9.6] [Reference Citation Analysis]
Number Citing Articles
1 Song SY, Chung JW, Han JK, Lim HG, Koh YH, Park JH, Lee HS, Kim CY. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol. 2001;12:313-320. [PMID: 11287508 DOI: 10.1016/S1051-0443(07)61910-1] [Cited by in Crossref: 120] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
2 Yang W, Chen MH, Wang MQ, Cui M, Gao W, Wu W, Wu JY, Dai Y, Yan K. Combination therapy of radiofrequency ablation and transarterial chemoembolization in recurrent hepatocellular carcinoma after hepatectomy compared with single treatment. Hepatol Res 2009;39:231-40. [PMID: 19054154 DOI: 10.1111/j.1872-034X.2008.00451.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
3 Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, Nakanuma Y, Kojiro M, Makuuchi M. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131:461-469. [PMID: 16890600 DOI: 10.1053/j.gastro.2006.05.021] [Cited by in Crossref: 524] [Cited by in F6Publishing: 460] [Article Influence: 34.9] [Reference Citation Analysis]
4 Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Nakashima Y, Ikeno H, Orito N, Notsumata K, Watanabe H, Toya D, Tanaka N, Matsui O. Main bile duct stricture occurring after transcatheter arterial chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2010;33:1168-1179. [PMID: 20058008 DOI: 10.1007/s00270-009-9781-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
5 Gaba RC, Lokken RP, Hickey RM, Lipnik AJ, Lewandowski RJ, Salem R, Brown DB, Walker TG, Silberzweig JE, Baerlocher MO, Echenique AM, Midia M, Mitchell JW, Padia SA, Ganguli S, Ward TJ, Weinstein JL, Nikolic B, Dariushnia SR; Society of Interventional Radiology Standards of Practice Committee. Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy. J Vasc Interv Radiol 2017;28:1210-1223.e3. [PMID: 28669744 DOI: 10.1016/j.jvir.2017.04.025] [Cited by in Crossref: 55] [Cited by in F6Publishing: 35] [Article Influence: 13.8] [Reference Citation Analysis]
6 Mizuki A, Tatemichi M, Tsukada N, Nagamatsu R, Kawaguchi M, Itoshima T, Maruyama S, Satou A, Imari Y, Kawatoko T. Addition of transcatheter arterial chemoembolization decreased local recurrence but had no survival benefit to percutaneous ethanol injection therapy for patients with small hepatocellular carcinoma: A multicenter randomized control study. Oncol Lett. 2010;1:855-859. [PMID: 22966394 DOI: 10.3892/ol_00000151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
7 Jia Z, Tian F, Jiang G. Ruptured hepatic carcinoma after transcatheter arterial chemoembolization. Curr Ther Res Clin Exp. 2013;74:41-43. [PMID: 24384870 DOI: 10.1016/j.curtheres.2012.12.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
8 Spina JC, Ulla M, Yeyati EL, Kucharczyk MC, Irusta H, Savluk JL, García-Mónaco R. MDCT findings after hepatic chemoembolization with DC-beads: what the radiologist needs to know. Abdom Imaging 2013;38:778-84. [PMID: 23053454 DOI: 10.1007/s00261-012-9963-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Marelli L, Shusang V, Senzolo M, Cholongitas E, Goode A, Yu D, Patch DW, Burroughs AK. Repeated courses of transarterial embolization with polyvinyl alcohol particles: 'long life elixir' in a cirrhotic patient with unresectable hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2007;19:329-32. [PMID: 17353698 DOI: 10.1097/MEG.0b013e3280298391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11:317-370. [PMID: 28620797 DOI: 10.1007/s12072-017-9799-9] [Cited by in Crossref: 661] [Cited by in F6Publishing: 571] [Article Influence: 165.3] [Reference Citation Analysis]
11 Maluf DG, Stravitz RT, Williams B, Cotterell AH, Mas VR, Heuman D, Luketic V, Shiffman ML, Sterling R, Posner MP, Fisher RA. Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experience. Transplant Proc 2007;39:153-9. [PMID: 17275495 DOI: 10.1016/j.transproceed.2006.10.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
12 Sun Q, Ma W, Gao Y, Zheng W, Zhang B, Peng Y. Meta-analysis: therapeutic effect of transcatheter arterial chemoembolization combined with compound kushen injection in hepatocellular carcinoma. Afr J Tradit Complement Altern Med 2012;9:178-88. [PMID: 23983333 DOI: 10.4314/ajtcam.v9i2.1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
13 Lee NJ, Shin JH, Lee SS, Park DH, Lee SK, Yoon HK. Transcatheter arterial embolization for iatrogenic bleeding after endoscopic ultrasound-guided pancreaticobiliary drainage. Diagn Interv Imaging 2018;99:717-24. [PMID: 30033142 DOI: 10.1016/j.diii.2018.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Giunchedi P, Maestri M, Gavini E, Dionigi P, Rassu G. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1. Expert Opin Drug Deliv 2013;10:679-90. [PMID: 23406440 DOI: 10.1517/17425247.2013.770733] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
15 Paye F, Farges O, Dahmane M, Vilgrain V, Flejou JF, Belghiti J. Cytolysis following chemoembolization for hepatocellular carcinoma. Br J Surg 1999;86:176-80. [PMID: 10100782 DOI: 10.1046/j.1365-2168.1999.01014.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 1.2] [Reference Citation Analysis]
16 Meng MB, Cui YL, Guan YS, Ying Z, Zheng MH, Yuan CK, Zhang RM. Traditional Chinese medicine plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma. J Altern Complement Med 2008;14:1027-42. [PMID: 18990050 DOI: 10.1089/acm.2008.0060] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
17 Choi JW, Chung JW, Cho YK, Kim YJ, Yoon J, Kim H, Jae HJ. Transarterial Chemoembolization for Hepatocellular Carcinomas with Central Bile Duct Invasion: Safety, Prognosis, and Predictive Factors. Cardiovasc Intervent Radiol 2015;38:937-45. [DOI: 10.1007/s00270-014-1032-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
18 Geschwind JF, Kaushik S, Ramsey DE, Choti MA, Fishman EK, Kobeiter H. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol. 2002;13:1163-1166. [PMID: 12427817 DOI: 10.1016/s1051-0443(07)61959-9] [Cited by in Crossref: 89] [Cited by in F6Publishing: 20] [Article Influence: 4.9] [Reference Citation Analysis]
19 Mahnken AH, Pereira PL, de Baère T. Interventional oncologic approaches to liver metastases. Radiology 2013;266:407-30. [PMID: 23362094 DOI: 10.1148/radiol.12112544] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 7.9] [Reference Citation Analysis]
20 Schlachterman A, Craft WW, Hilgenfeldt E, Mitra A, Cabrera R. Current and future treatments for hepatocellular carcinoma. World J Gastroenterol. 2015;21:8478-8491. [PMID: 26229392 DOI: 10.3748/wjg.v21.i28.8478] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 82] [Article Influence: 18.8] [Reference Citation Analysis]
21 Zhuang X, Wang Q, Wang N, Hou X, Zhang J, Chi H. Effects of combining transarterial chemoembolization with percutaneous microwave coagulation therapy for hepatocellular carcinoma abutting the diaphragm. Minim Invasive Ther Allied Technol 2016;25:107-12. [PMID: 26560859 DOI: 10.3109/13645706.2015.1103751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
22 Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Sugimori N, Igarashi S, Nakashima Y, Notsumata K, Toya D, Tanaka N. Chemoembolization for the treatment of large hepatocellular carcinoma. J Vasc Interv Radiol. 2010;21:1226-1234. [PMID: 20598571 DOI: 10.1016/j.jvir.2010.04.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
23 Hui TC, Pua U. Arterial Portography during Transarterial Chemoembolization: Still a Necessity in the Age of Contrast-enhanced Cross-sectional Imaging? Journal of Vascular and Interventional Radiology 2014;25:41-6. [DOI: 10.1016/j.jvir.2013.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
24 Takayasu K, Muramatsu Y, Maeda T, Iwata R, Furukawa H, Muramatsu Y, Moriyama N, Okusaka T, Okada S, Ueno H. Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates. AJR Am J Roentgenol. 2001;176:681-688. [PMID: 11222205 DOI: 10.2214/ajr.176.3.1760681] [Cited by in Crossref: 121] [Cited by in F6Publishing: 109] [Article Influence: 6.1] [Reference Citation Analysis]
25 de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. Journal of Hepatology 2012;56:S75-87. [DOI: 10.1016/s0168-8278(12)60009-9] [Cited by in Crossref: 363] [Cited by in F6Publishing: 188] [Article Influence: 40.3] [Reference Citation Analysis]
26 Kalva SP, Pectasides M, Liu R, Rachamreddy N, Surakanti S, Yeddula K, Ganguli S, Wicky S, Blaszkowsky LS, Zhu AX. Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma. Cardiovasc Intervent Radiol. 2014;37:381-387. [PMID: 23754191 DOI: 10.1007/s00270-013-0654-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
27 Jang ES, Yoon JH, Chung JW, Cho EJ, Yu SJ, Lee JH, Kim YJ, Lee HS, Kim CY. Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization. J Cancer Res Clin Oncol. 2013;139:635-643. [PMID: 23283527 DOI: 10.1007/s00432-012-1364-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
28 Sahu SK, Chawla YK, Dhiman RK, Singh V, Duseja A, Taneja S, Kalra N, Gorsi U. Rupture of Hepatocellular Carcinoma: A Review of Literature. J Clin Exp Hepatol 2019;9:245-56. [PMID: 31024207 DOI: 10.1016/j.jceh.2018.04.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
29 Xia J, Ren Z, Ye S, Sharma D, Lin Z, Gan Y, Chen Y, Ge N, Ma Z, Wu Z. Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Eur J Radiol. 2006;59:407-412. [PMID: 16621394 DOI: 10.1016/j.ejrad.2006.03.002] [Cited by in Crossref: 101] [Cited by in F6Publishing: 72] [Article Influence: 6.7] [Reference Citation Analysis]
30 Hur S, Chung JW, Zhou CG, Lee JH, Cho S, Kim M, Lee M, Kim HC, Jae HJ. Arteries of the falciform ligament on C-arm CT hepatic arteriography: The hepatic falciform artery and the Sappey's superior artery. Eur Radiol 2017;27:1440-7. [PMID: 27510629 DOI: 10.1007/s00330-016-4523-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
31 Miura JT, Gamblin TC. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis. Surg Oncol Clin N Am 2015;24:149-66. [PMID: 25444473 DOI: 10.1016/j.soc.2014.09.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
32 Addario L, Di Costanzo GG, Tritto G, Cavaglià E, Angrisani B, Ascione A. Fatal ischemic acute pancreatitis complicating trans-catheter arterial embolization of small hepatocellular carcinoma: do the risks outweigh the benefits? J Hepatol. 2008;49:149-152. [PMID: 18486260 DOI: 10.1016/j.jhep.2008.02.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
33 Czauderna P, Zbrzezniak G, Narozanski W, Sznurkowska K, Skoczylas-Stoba B, Stoba C. Pulmonary embolism: a fatal complication of arterial chemoembolization for advanced hepatocellular carcinoma. J Pediatr Surg. 2005;40:1647-1650. [PMID: 16227000 DOI: 10.1016/j.jpedsurg.2005.06.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
34 Adhoute X, Penaranda G, Castellani P, Perrier H, Bourliere M. Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system? World J Hepatol. 2015;7:521-531. [PMID: 25848475 DOI: 10.4254/wjh.v7.i3.521] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
35 Boucher E, Garin E, Guylligomarc’h A, Olivié D, Boudjema K, Raoul JL. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma. Radiother Oncol. 2007;82:76-82. [PMID: 17141900 DOI: 10.1016/j.radonc.2006.11.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
36 Sakamoto I, Iwanaga S, Nagaoki K, Matsuoka Y, Ashizawa K, Uetani M, Fukuda T, Okimoto T, Okudaira S, Omagari K. Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. AJR Am J Roentgenol. 2003;181:79-87. [PMID: 12818833 DOI: 10.2214/ajr.181.1.1810079] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
37 Bruix J, Cheng AL, Meinhardt G, Nakajima K, De Sanctis Y, Llovet J. Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies. J Hepatol. 2017;67:999-1008. [PMID: 28687477 DOI: 10.1016/j.jhep.2017.06.026] [Cited by in Crossref: 234] [Cited by in F6Publishing: 205] [Article Influence: 58.5] [Reference Citation Analysis]
38 Szemitko M, Golubinska-Szemitko E, Sienko J, Falkowski A. Complications Following Irinotecan-Loaded Microsphere Chemoembolization of Colorectal Metastatic Liver Lesions Associated with Hepatic-Artery Branch Temporary Stasis. Curr Oncol 2021;28:2296-307. [PMID: 34203031 DOI: 10.3390/curroncol28030211] [Reference Citation Analysis]
39 Xu H, Yu X, Hu J. The Risk Assessment and Clinical Research of Bile Duct Injury After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma. Cancer Manag Res 2021;13:5039-52. [PMID: 34234549 DOI: 10.2147/CMAR.S303172] [Reference Citation Analysis]
40 Basile A, Carrafiello G, Ierardi AM, Tsetis D, Brountzos E. Quality-improvement guidelines for hepatic transarterial chemoembolization. Cardiovasc Intervent Radiol. 2012;35:765-774. [PMID: 22648700 DOI: 10.1007/s00270-012-0423-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
41 Tsao JI, DeSanctis J, Rossi RL, Oberfield RA. Hepatic malignancies. Surg Clin North Am. 2000;80:603-632. [PMID: 10836009 DOI: 10.1016/s0039-6109(05)70203-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
42 Shim JH, Park JW, Kim JH, An M, Kong SY, Nam BH, Choi JI, Kim HB, Lee WJ, Kim CM. Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients. Cancer Sci. 2008;99:2037-2044. [PMID: 19016764 DOI: 10.1111/j.1349-7006.2008.00909.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 70] [Article Influence: 1.6] [Reference Citation Analysis]
43 Pinter M, Hucke F, Graziadei I, Vogel W, Maieron A, Königsberg R, Stauber R, Grünberger B, Müller C, Kölblinger C. Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib. Radiology. 2012;263:590-599. [PMID: 22438359 DOI: 10.1148/radiol.12111550] [Cited by in Crossref: 126] [Cited by in F6Publishing: 113] [Article Influence: 14.0] [Reference Citation Analysis]
44 Kim MU, Kim HC, Chung JW, An S, Seong NJ, Jae HJ, Park JH. Hepatocellular carcinoma: prediction of blood supply from an intercostal artery with multidetector row computed tomography. J Vasc Interv Radiol. 2011;22:1403-1408. e1. [PMID: 21763155 DOI: 10.1016/j.jvir.2011.05.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
45 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int. 2010;4:439-474. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Cited by in Crossref: 684] [Cited by in F6Publishing: 653] [Article Influence: 62.2] [Reference Citation Analysis]
46 Nicolini A, Fasani P, Manini MA, Martinetti L, Forzenigo LV, Iavarone M, Crespi S, Rossi G, Biondetti P, Colombo M, Sangiovanni A. Transarterial embolization with microspheres in the treatment of monofocal HCC. Dig Liver Dis 2009;41:143-9. [PMID: 18436490 DOI: 10.1016/j.dld.2008.03.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
47 Lee H, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction: A prospective controlled study. Cancer 1997;79:2087-94. [DOI: 10.1002/(sici)1097-0142(19970601)79:11<2087::aid-cncr5>3.0.co;2-m] [Cited by in Crossref: 153] [Cited by in F6Publishing: 1] [Article Influence: 6.4] [Reference Citation Analysis]
48 Kim HK, Chung Y, Song B, Yang SH, Yoon H, Yu E, Sung K, Lee YS, Lee SG, Suh DJ. Ischemic Bile Duct Injury as a Serious Complication After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma: . Journal of Clinical Gastroenterology 2001;32:423-7. [DOI: 10.1097/00004836-200105000-00013] [Cited by in Crossref: 76] [Cited by in F6Publishing: 61] [Article Influence: 3.8] [Reference Citation Analysis]
49 Kanzaki H, Nouso K, Miyahara K, Kajikawa N, Kobayashi S, Sakakihara I, Iwadow S, Uematsu S, Okamoto R, Shiraga K, Mizuno M, Araki Y. A case of hepatocellular carcinoma with skin injury of the upper abdominal wall after transcatheter arterial chemoembolization: a case report. Cases J 2009;2:7197. [PMID: 19918514 DOI: 10.4076/1757-1626-2-7197] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
50 Lim C, Compagnon P, Sebagh M, Salloum C, Calderaro J, Luciani A, Pascal G, Laurent A, Levesque E, Maggi U, Feray C, Cherqui D, Castaing D, Azoulay D. Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery. HPB (Oxford). 2015;17:611-623. [PMID: 25980326 DOI: 10.1111/hpb.12416] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
51 Deipolyi AR, Oklu R, Al-Ansari S, Zhu AX, Goyal L, Ganguli S. Safety and efficacy of 70-150 μm and 100-300 μm drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2015;26:516-522. [PMID: 25704226 DOI: 10.1016/j.jvir.2014.12.020] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
52 Koda M, Murawaki Y, Mitsuda A, Oyama K, Okamoto K, Idobe Y, Suou T, Kawasaki H. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: A randomized control study. Cancer 2001;92:1516-24. [DOI: 10.1002/1097-0142(20010915)92:6<1516::aid-cncr1477>3.0.co;2-i] [Cited by in Crossref: 104] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
53 Mezhir JJ, Fong Y, Fleischer D, Seo SK, D'Amico F, Petre E, Covey AM, Getrajdman GI, Thornton RH, Solomon SB, Jarnagin WR, Brown KT. Pyogenic abscess after hepatic artery embolization: a rare but potentially lethal complication. J Vasc Interv Radiol 2011;22:177-82. [PMID: 21195630 DOI: 10.1016/j.jvir.2010.10.014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
54 Caturelli E, Siena DA, Villani MR, Schiavone G, Nardella M, Balzana S, Florio F. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology. 2000;215:123-128. [PMID: 10751477 DOI: 10.1148/radiology.215.1.r00ap21123] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 3.2] [Reference Citation Analysis]
55 Acunaş B, Rozanes I. Hepatocellular carcinoma: treatment with transcatheter arterial chemoembolization. Eur J Radiol 1999;32:86-9. [PMID: 10580325 DOI: 10.1016/s0720-048x(99)00117-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
56 Yu J, Kim KW, Park M, Yoon S. Bile Duct Injuries Leading to Portal Vein Obliteration after Transcatheter Arterial Chemoembolization in the Liver: CT Findings and Initial Observations. Radiology 2001;221:429-36. [DOI: 10.1148/radiol.2212010339] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
57 Song S, Chung JW, Lim HG, Park JH. Nonhepatic Arteries Originating from the Hepatic Arteries: Angiographic Analysis in 250 Patients. Journal of Vascular and Interventional Radiology 2006;17:461-9. [DOI: 10.1097/01.rvi.0000202718.16416.18] [Cited by in Crossref: 58] [Cited by in F6Publishing: 13] [Article Influence: 3.9] [Reference Citation Analysis]
58 Reyes DK, Vossen JA, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF. Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States. Cancer J 2009;15:526-32. [PMID: 20010173 DOI: 10.1097/PPO.0b013e3181c5214b] [Cited by in Crossref: 88] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
59 Kim W, Clark TW, Baum RA, Soulen MC. Risk Factors for Liver Abscess Formation after Hepatic Chemoembolization. Journal of Vascular and Interventional Radiology 2001;12:965-8. [DOI: 10.1016/s1051-0443(07)61577-2] [Cited by in Crossref: 159] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
60 Dhand S, Gupta R. Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome. Semin Intervent Radiol. 2011;28:207-211. [PMID: 22654264 DOI: 10.1055/s-0031-1280666] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
61 Pleguezuelo M, Marelli L, Misseri M, Germani G, Calvaruso V, Xiruochakis E, Pinelopi M, Burroughs AK. TACE versus TAE as therapy for hepatocellular carcinoma. Expert Rev Anticancer Ther. 2008;8:1623-1641. [PMID: 18925854 DOI: 10.1586/14737140.8.10.1623] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 4.7] [Reference Citation Analysis]
62 Trinchet JC, Ganne-Carrie N, Beaugrand M. Review article: intra-arterial treatments in patients with hepatocellular carcinoma. Aliment Pharmacol Ther. 2003;17 Suppl 2:111-118. [PMID: 12786622 DOI: 10.1046/j.1365-2036.17.s2.19.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
63 Huang YS, Chiang JH, Wu JC, Chang FY, Lee SD. Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test. Am J Gastroenterol. 2002;97:1223-1227. [PMID: 12014732 DOI: 10.1111/j.1572-0241.2002.05709.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
64 Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H, Kudo M, Lee JM, Choi BI, Poon RT, Shiina S, Cheng AL, Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK, Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF, Sarin SK. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4:439-74. [PMID: 20827404 DOI: 10.1007/s12072-010-9165-7] [Reference Citation Analysis]
65 Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61-72. [PMID: 18177818 DOI: 10.1016/s1470-2045(07)70410-2] [Cited by in Crossref: 1032] [Cited by in F6Publishing: 393] [Article Influence: 79.4] [Reference Citation Analysis]
66 Kim SK, Lim HK, Kim YH, Lee WJ, Lee SJ, Kim SH, Lim JH, Kim SA. Hepatocellular Carcinoma Treated with Radio-frequency Ablation: Spectrum of Imaging Findings. RadioGraphics 2003;23:107-21. [DOI: 10.1148/rg.231025055] [Cited by in Crossref: 92] [Cited by in F6Publishing: 78] [Article Influence: 5.1] [Reference Citation Analysis]
67 Marrache F, Vullierme MP, Roy C, El Assoued Y, Couvelard A, O'Toole D, Mitry E, Hentic O, Hammel P, Lévy P, Ravaud P, Rougier P, Ruszniewski P. Arterial phase enhancement and body mass index are predictors of response to chemoembolisation for liver metastases of endocrine tumours. Br J Cancer 2007;96:49-55. [PMID: 17164755 DOI: 10.1038/sj.bjc.6603526] [Cited by in Crossref: 65] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
68 Korean Liver Cancer Association., National Cancer Center. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Gut Liver 2019;13:227-99. [PMID: 31060120 DOI: 10.5009/gnl19024] [Cited by in Crossref: 90] [Cited by in F6Publishing: 75] [Article Influence: 90.0] [Reference Citation Analysis]
69 Shim JH, Park JW, Choi JI, Kim HB, Lee WJ, Kim CM. Does postembolization fever after chemoembolization have prognostic significance for survival in patients with unresectable hepatocellular carcinoma? J Vasc Interv Radiol. 2009;20:209-216. [PMID: 19084432 DOI: 10.1016/j.jvir.2008.10.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
70 Widman A, Speranzini MB, Oliveira IRS, Saad WA, Fratezzi AC, Cerri GG. Fístulas arteriovenosas intra-hepáticas transtumorais (diagnóstico, importância e propostas de tratamento). Arq Gastroenterol 2000;37:13-9. [DOI: 10.1590/s0004-28032000000100004] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
71 Fairchild AH, White SB. Decision Making in Interventional Oncology: Intra-arterial Therapies for Metastatic Colorectal Cancer-Y90 and Chemoembolization. Semin Intervent Radiol 2017;34:87-91. [PMID: 28579675 DOI: 10.1055/s-0037-1601854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Pijl ME, Pattynama PM, van Hoek B. Liver rupture after transcatheter arterial chemoembolization of a giant hepatocellular carcinoma. J Vasc Interv Radiol 1999;10:895-7. [PMID: 10435707 DOI: 10.1016/s1051-0443(99)70134-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Brown DB, Cardella JF, Sacks D, Goldberg SN, Gervais DA, Rajan D, Vedantham S, Miller DL, Brountzos EN, Grassi CJ, Towbin RB. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol 2006;17:225-32. [PMID: 16517768 DOI: 10.1097/01.RVI.0000195330.47954.48] [Cited by in Crossref: 80] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
74 Kang B, Kim HC, Chung JW, Hur S, Joo SM, Jae HJ, Park JH. Safety of chemotherapeutic infusion or chemoembolization for hepatocellular carcinoma supplied exclusively by the cystic artery. Cardiovasc Intervent Radiol 2013;36:1313-9. [PMID: 23262478 DOI: 10.1007/s00270-012-0542-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
75 Luz JH, Luz PM, Martin HS, Gouveia HR, Levigard RB, Nogueira FD, Rodrigues BC, de Miranda TN, Mamede MH. DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center. Cancer Imaging 2017;17:5. [PMID: 28166821 DOI: 10.1186/s40644-017-0108-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
76 Patel NH, Hahn D, Rapp S, Bergan K, Coldwell DM. Hepatic artery embolization: factors predisposing to postembolization pain and nausea. J Vasc Interv Radiol. 2000;11:453-460. [PMID: 10787203 DOI: 10.1016/S1051-0443(07)61377-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
77 Wang J, He XD, Zhang YC. Antibiotic prophylaxis in transarterial therapy of hepatocellular carcinoma: a meta-analysis. Can J Gastroenterol 2012;26:85-91. [PMID: 22312607 DOI: 10.1155/2012/375956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
78 Yamada K, Izaki K, Sugimoto K, Mayahara H, Morita Y, Yoden E, Matsumoto S, Soejima T, Sugimura K. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2003;57:113-119. [PMID: 12909223 DOI: 10.1016/s0360-3016(03)00434-6] [Cited by in Crossref: 139] [Cited by in F6Publishing: 53] [Article Influence: 7.7] [Reference Citation Analysis]
79 Terzi E, Piscaglia F, Forlani L, Mosconi C, Renzulli M, Bolondi L, Golfieri R; BLOG-Bologna Liver Oncology Group, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy. TACE performed in patients with a single nodule of hepatocellular carcinoma. BMC Cancer 2014;14:601. [PMID: 25139639 DOI: 10.1186/1471-2407-14-601] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
80 Sun Z, Li G, Ai X, Luo B, Wen Y, Zhao Z, Dong S, Guan J. Hepatic and biliary damage after transarterial chemoembolization for malignant hepatic tumors: incidence, diagnosis, treatment, outcome and mechanism. Crit Rev Oncol Hematol 2011;79:164-74. [PMID: 20719529 DOI: 10.1016/j.critrevonc.2010.07.019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
81 López-Benítez R, Richter GM, Kauczor HU, Stampfl S, Kladeck J, Radeleff BA, Neukamm M, Hallscheidt PJ. Analysis of nontarget embolization mechanisms during embolization and chemoembolization procedures. Cardiovasc Intervent Radiol 2009;32:615-22. [PMID: 19387732 DOI: 10.1007/s00270-009-9568-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
82 Somma F, D'Angelo R, Serra N, Gatta G, Grassi R, Fiore F. Use of Ethanol in the Trans-Arterial Lipiodol Embolization (TAELE) of Intermediated-Stage HCC: Is This Safer than Conventional Trans-Arterial Chemo-Embolization (c-TACE)? PLoS One 2015;10:e0129573. [PMID: 26110810 DOI: 10.1371/journal.pone.0129573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
83 Clark TW. Complications of hepatic chemoembolization. Semin Intervent Radiol. 2006;23:119-125. [PMID: 21326755 DOI: 10.1055/s-2006-941442] [Cited by in Crossref: 77] [Cited by in F6Publishing: 56] [Article Influence: 7.7] [Reference Citation Analysis]
84 Maeda N, Osuga K, Mikami K, Higashihara H, Onishi H, Nakaya Y, Tatsumi M, Hori M, Kim T, Tomoda K, Nakamura H. Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med 2008;26:206-12. [DOI: 10.1007/s11604-007-0216-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
85 Lee HS, Kim KM, Yoon JH, Lee TR, Suh KS, Lee KU, Chung JW, Park JH, Kim CY. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol. 2002;20:4459-4465. [PMID: 12431969 DOI: 10.1200/jco.2002.02.013] [Cited by in Crossref: 86] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
86 Maluf D, Fisher RA, Maroney T, Cotterell A, Fulcher A, Tisnado J, Contos M, Luketic V, Stravitz R, Shiffman M. Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacy. Am J Transplant. 2003;3:312-317. [PMID: 12614287 DOI: 10.1034/j.1600-6143.2003.00041.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
87 Sangro B. Chemoembolization and radioembolization. Best Practice & Research Clinical Gastroenterology 2014;28:909-19. [DOI: 10.1016/j.bpg.2014.08.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
88 Kennedy AS, Sangro B. Nonsurgical treatment for localized hepatocellular carcinoma. Curr Oncol Rep. 2014;16:373. [PMID: 24488546 DOI: 10.1007/s11912-013-0373-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
89 Abramson RG, Rosen MP, Perry LJ, Brophy DP, Raeburn SL, Stuart KE. Cost-effectiveness of hepatic arterial chemoembolization for colorectal liver metastases refractory to systemic chemotherapy. Radiology 2000;216:485-91. [PMID: 10924575 DOI: 10.1148/radiology.216.2.r00au26485] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
90 Butt AS, Mujtaba G, Anand S, Krishnaiah M. Management of biliopleural fistula after transarterial chemoembolization of a liver lesion. Can J Gastroenterol 2010;24:281-3. [PMID: 20485700 DOI: 10.1155/2010/790726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
91 Mascarenhas NB, Mulcahy MF, Lewandowski RJ, Salem R, Ryu RK. Hepatic Abscess After Yttrium-90 Radioembolization for Islet-Cell Tumor Hepatic Metastasis. Cardiovasc Intervent Radiol 2010;33:650-3. [DOI: 10.1007/s00270-009-9617-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
92 Zhao W, Hou X, Li H, Guo J, Cai L, Duan Y, Du H, Shao X, Diao Z, Li C. Imaging features and outcomes in patients with ruptured hepatocellular carcinoma following transcatheter arterial chemoembolization: a retrospective clinical study. J Int Med Res 2021;49:3000605211007722. [PMID: 33853433 DOI: 10.1177/03000605211007722] [Reference Citation Analysis]
93 Gonsalves CF, Brown DB. Chemoembolization of hepatic malignancy. Abdom Imaging. 2009;34:557-565. [PMID: 18668189 DOI: 10.1007/s00261-008-9446-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
94 Meng MB, Cui YL, Lu Y, She B, Chen Y, Guan YS, Zhang RM. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis. Radiother Oncol. 2009;92:184-194. [PMID: 19042048 DOI: 10.1016/j.radonc.2008.11.002] [Cited by in Crossref: 97] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]
95 Baek JH, Chung JW, Jae HJ, Lee W, Park JH. A new technique for superselective catheterization of arteries: preshaping of a micro-guide wire into a shepherd's hook form. Korean J Radiol 2007;8:225-30. [PMID: 17554190 DOI: 10.3348/kjr.2007.8.3.225] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
96 Kettenbach J, Stadler A, Katzler IV, Schernthaner R, Blum M, Lammer J, Rand T. Drug-loaded microspheres for the treatment of liver cancer: review of current results. Cardiovasc Intervent Radiol. 2008;31:468-476. [PMID: 18228095 DOI: 10.1007/s00270-007-9280-6] [Cited by in Crossref: 112] [Cited by in F6Publishing: 85] [Article Influence: 8.6] [Reference Citation Analysis]
97 Brown DB, Nikolic B, Covey AM, Nutting CW, Saad WE, Salem R, Sofocleous CT, Sze DY; Society of Interventional Radiology Standards of Practice Committee. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol. 2012;23:287-294. [PMID: 22284821 DOI: 10.1016/j.jvir.2011.11.029] [Cited by in Crossref: 120] [Cited by in F6Publishing: 83] [Article Influence: 13.3] [Reference Citation Analysis]
98 Rammohan A, Sathyanesan J, Ramaswami S, Lakshmanan A, Senthil-Kumar P, Srinivasan UP, Ramasamy R, Ravichandran P. Embolization of liver tumors: Past, present and future. World J Radiol. 2012;4:405-412. [PMID: 23024842 DOI: 10.4329/wjr.v4.i9.405] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
99 Sun W, Xu F, Li X, Li CR. A Case Series of Liver Abscess Formation after Transcatheter Arterial Chemoembolization for Hepatic Tumors. Chin Med J (Engl) 2017;130:1314-9. [PMID: 28524831 DOI: 10.4103/0366-6999.206345] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
100 Lee DH, Chung JW, Kim H, Jae HJ, Yoon CJ, Kang SG, Jeon UB, So YH, Yin YH, Park JH. Development of Diaphragmatic Weakness after Transcatheter Arterial Chemoembolization of the Right Inferior Phrenic Artery: Frequency and Determinant Factors. Journal of Vascular and Interventional Radiology 2009;20:484-9. [DOI: 10.1016/j.jvir.2008.11.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
101 Leung DA, Goin JE, Sickles C, Raskay BJ, Soulen MC. Determinants of postembolization syndrome after hepatic chemoembolization. J Vasc Interv Radiol. 2001;12:321-326. [PMID: 11287509 DOI: 10.1016/s1051-0443(07)61911-3] [Cited by in Crossref: 150] [Cited by in F6Publishing: 41] [Article Influence: 7.5] [Reference Citation Analysis]
102 Qu K, Yan Z, Wu Y, Chen Y, Qu P, Xu X, Yuan P, Huang X, Xing J, Zhang H, Liu C, Zhang J. Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma: Chemoembolization aggravated fibrosis. J Gastroenterol Hepatol 2015;30:925-32. [DOI: 10.1111/jgh.12873] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
103 Akhlaghpoor S, Torkian P, Golzarian J. Transarterial Bleomycin-Lipiodol Embolization (B/LE) for Symptomatic Giant Hepatic Hemangioma. Cardiovasc Intervent Radiol. 2018;41:1674-1682. [PMID: 29922860 DOI: 10.1007/s00270-018-2010-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
104 Kumar A, Acharya SK, Singh SP, Saraswat VA, Arora A, Duseja A, Goenka MK, Jain D, Kar P, Kumar M, Kumaran V, Mohandas KM, Panda D, Paul SB, Ramachandran J, Ramesh H, Rao PN, Shah SR, Sharma H, Thandassery RB; (The INASL Task-Force on Hepatocellular Carcinoma). The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations. J Clin Exp Hepatol 2014;4:S3-S26. [PMID: 25755608 DOI: 10.1016/j.jceh.2014.04.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
105 Arora R, Soulen MC, Haskal ZJ. Cutaneous Complications of Hepatic Chemoembolization via Extrahepatic Collaterals. Journal of Vascular and Interventional Radiology 1999;10:1351-6. [DOI: 10.1016/s1051-0443(99)70242-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
106 Choi BI, Lee KH, Han JK, Lee JM. Hepatic arterioportal shunts: dynamic CT and MR features. Korean J Radiol. 2002;3:1-15. [PMID: 11919473 DOI: 10.3348/kjr.2002.3.1.1] [Cited by in Crossref: 81] [Cited by in F6Publishing: 64] [Article Influence: 4.3] [Reference Citation Analysis]
107 Wigmore SJ, Redhead DN, Thomson BN, Currie EJ, Parks RW, Madhavan KK, Garden OJ. Postchemoembolisation syndrome--tumour necrosis or hepatocyte injury? Br J Cancer. 2003;89:1423-1427. [PMID: 14562011 DOI: 10.1038/sj.bjc.6601329] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
108 Rajan DK, Soulen MC, Clark TW, Baum RA, Haskal ZJ, Shlansky-goldberg RD, Freiman DB. Sarcomas Metastatic to the Liver: Response and Survival after Cisplatin, Doxorubicin, Mitomycin-C, Ethiodol, and Polyvinyl Alcohol Chemoembolization. Journal of Vascular and Interventional Radiology 2001;12:187-93. [DOI: 10.1016/s1051-0443(07)61824-7] [Cited by in Crossref: 64] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
109 Guiu B, Deschamps F, Aho S, Munck F, Dromain C, Boige V, Malka D, Leboulleux S, Ducreux M, Schlumberger M. Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads. J Hepatol. 2012;56:609-617. [PMID: 22027582 DOI: 10.1016/j.jhep.2011.09.012] [Cited by in Crossref: 110] [Cited by in F6Publishing: 85] [Article Influence: 11.0] [Reference Citation Analysis]
110 Kang JW, Kim JH, Ko GY, Gwon DI, Yoon HK, Sung KB. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt. Acta Radiol. 2012;53:545-550. [PMID: 22547388 DOI: 10.1258/ar.2012.110476] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
111 de Baère T, Denys A, Briquet R, Chevallier P, Dufaux J, Roche A. Modification of Arterial and Portal Hemodynamics after Injection of Iodized Oils and Different Emulsions of Iodized Oils in the Hepatic Artery: An Experimental Study. Journal of Vascular and Interventional Radiology 1998;9:305-10. [DOI: 10.1016/s1051-0443(98)70273-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
112 Cho JY, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW. The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma. Liver Int. 2014;34:795-801. [PMID: 24350564 DOI: 10.1111/liv.12445] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
113 Reichman TW, Anthony T, Millis JM, Testa G. Uncharacteristically early fatal intraperitoneal rupture of hepatocellular carcinoma following transarterial chemoembolization. Digestive and Liver Disease 2009;41:175-6. [DOI: 10.1016/j.dld.2008.08.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
114 Czauderna P, Zbrzezniak G, Narozanski W, Korzon M, Wyszomirska M, Stoba C. Preliminary experience with arterial chemoembolization for hepatoblastoma and hepatocellular carcinoma in children. Pediatr Blood Cancer 2006;46:825-8. [DOI: 10.1002/pbc.20422] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
115 Adhoute X, Penaranda G, Naude S, Raoul JL, Perrier H, Bayle O, Monnet O, Beaurain P, Bazin C, Pol B, Folgoc GL, Castellani P, Bronowicki JP, Bourlière M. Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process. Journal of Hepatology 2015;62:855-62. [DOI: 10.1016/j.jhep.2014.11.014] [Cited by in Crossref: 81] [Cited by in F6Publishing: 59] [Article Influence: 13.5] [Reference Citation Analysis]
116 Moon E, Tam MD, Kikano RN, Karuppasamy K. Prophylactic antibiotic guidelines in modern interventional radiology practice. Semin Intervent Radiol 2010;27:327-37. [PMID: 22550374 DOI: 10.1055/s-0030-1267853] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
117 Dodd GD, Napier D, Schoolfield JD, Hubbard L. Percutaneous Radiofrequency Ablation of Hepatic Tumors: Postablation Syndrome. American Journal of Roentgenology 2005;185:51-7. [DOI: 10.2214/ajr.185.1.01850051] [Cited by in Crossref: 50] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
118 Sakamoto N, Monzawa S, Nagano H, Nishizaki H, Arai Y, Sugimura K. Acute Tumor Lysis Syndrome Caused by Transcatheter Oily Chemoembolization in a Patient with a Large Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2007;30:508-11. [DOI: 10.1007/s00270-005-0240-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
119 Kim H, Chung JW, Choi SH, Yoon J, Lee H, Jae HJ, Lee W, Park JH. Hepatocellular Carcinoma with Internal Mammary Artery Supply: Feasibility and Efficacy of Transarterial Chemoembolization and Factors Affecting Patient Prognosis. Journal of Vascular and Interventional Radiology 2007;18:611-9. [DOI: 10.1016/j.jvir.2007.02.023] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
120 Liu DM, Kennedy A, Turner D, Rose SC, Kee ST, Whiting S, Murthy R, Nutting C, Heran M, Lewandowski R. Minimally invasive techniques in management of hepatic neuroendocrine metastatic disease. Am J Clin Oncol. 2009;32:200-215. [PMID: 19346815 DOI: 10.1097/coc.0b013e318172b3b6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
121 Mascarenhas N, Ryu RK, Salem R. Hepatic radioembolization complicated by abscess. Semin Intervent Radiol 2011;28:222-5. [PMID: 22654267 DOI: 10.1055/s-0031-1280669] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
122 Choi JW, Cho HJ, Park JH, Baek SY, Chung JW, Kim DD, Kim HC. Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads. PLoS One 2014;9:e115898. [PMID: 25551760 DOI: 10.1371/journal.pone.0115898] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
123 de Baere T, Taourel P, Tubiana JM, Kuoch V, Ducreux M, Lumbroso J, Roche AJ. Hepatic Intraarterial 131 I Iodized Oil for Treatment of Hepatocellular Carcinoma in Patients with Impeded Portal Venous Flow. Radiology 1999;212:665-8. [DOI: 10.1148/radiology.212.3.r99se03665] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
124 Lee KH, Sung KB, Lee DY, Park SJ, Kim KW, Yu JS. Transcatheter arterial chemoembolization for hepatocellular carcinoma: anatomic and hemodynamic considerations in the hepatic artery and portal vein. Radiographics. 2002;22:1077-1091. [PMID: 12235337 DOI: 10.1148/radiographics.22.5.g02se191077] [Cited by in Crossref: 43] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
125 Carrafiello G, Laganà D, Ianniello A, Dionigi G, Novario R, Recaldini C, Mangini M, Cuffari S, Fugazzola C. Post-radiofrequency ablation syndrome after percutaneous radiofrequency of abdominal tumours: one centre experience and review of published works. Australas Radiol 2007;51:550-4. [PMID: 17958690 DOI: 10.1111/j.1440-1673.2007.01871.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
126 Park YH, Kang SH, Kim SU, Kim DY, Park JY, Ahn SH, Han KH, Chon CY. [A case of hepaticoduodenal fistula development after transarterial chemoembolization in patient with hepatocellular carcinoma]. Korean J Gastroenterol 2011;58:149-52. [PMID: 21960103 DOI: 10.4166/kjg.2011.58.3.149] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
127 Kim P, Prapong W, Sze DY, So SK, Razavi MK. Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Tech Vasc Interv Radiol 2002;5:127-31. [PMID: 12524643 DOI: 10.1053/tvir.2002.36424] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
128 Shin JU, Kim KM, Shin SW, Min SY, Park SU, Sinn DH, Gwak GY, Choi MS, Lee JH, Paik SW, Yoo BC, Koh KC. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma. Dig Liver Dis. 2014;46:813-817. [PMID: 24881853 DOI: 10.1016/j.dld.2014.05.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
129 Dabbous HK, Ali-Eldin FA, Montasser IM. Role of procalcitonin in diagnosis of bacterial infection in trans-arterial chemoembolisation treated hepatocellular carcinoma patients. Arab J Gastroenterol 2015;16:10-3. [PMID: 25865041 DOI: 10.1016/j.ajg.2015.03.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
130 Kang BK, Kim JH, Kim KM, Ko GY, Yoon HK, Gwon DI, Sung KB. Transcatheter arterial chemoembolization for hepatocellular carcinoma after attempted portal vein embolization in 25 patients. AJR Am J Roentgenol. 2009;193:W446-W451. [PMID: 19843726 DOI: 10.2214/AJR.09.2479] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
131 Ahrar K, Gupta S. Hepatic artery embolization for hepatocellular carcinoma: technique, patient selection, and outcomes. Surg Oncol Clin N Am. 2003;12:105-126. [PMID: 12735133 DOI: 10.1016/s1055-3207(02)00089-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
132 Liu DM, Salem R, Bui JT, Courtney A, Barakat O, Sergie Z, Atassi B, Barrett K, Gowland P, Oman B. Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol. 2005;16:911-935. [PMID: 16002500 DOI: 10.1097/01.rvi.0000164324.79242.b2] [Cited by in Crossref: 182] [Cited by in F6Publishing: 28] [Article Influence: 11.4] [Reference Citation Analysis]
133 Chung GE, Lee JH, Kim HY, Hwang SY, Kim JS, Chung JW, Yoon JH, Lee HS, Kim YJ. Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival. Radiology. 2011;258:627-634. [PMID: 21273524 DOI: 10.1148/radiol.10101058] [Cited by in Crossref: 165] [Cited by in F6Publishing: 145] [Article Influence: 16.5] [Reference Citation Analysis]
134 Lewandowski RJ, Salem R. Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver. Semin Intervent Radiol. 2006;23:64-72. [PMID: 21326721 DOI: 10.1055/s-2006-939842] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
135 Livraghi T, Benedini V, Lazzaroni S, Meloni F, Torzilli G, Vettori C. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma. Cancer 1998;83:48-57. [DOI: 10.1002/(sici)1097-0142(19980701)83:1<48::aid-cncr7>3.0.co;2-a] [Cited by in Crossref: 97] [Article Influence: 4.2] [Reference Citation Analysis]
136 Kothary N, Weintraub JL, Susman J, Rundback JH. Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. J Vasc Interv Radiol. 2007;18:1517-1526; quiz 1527. [PMID: 18057286 DOI: 10.1016/j.jvir.2007.07.035] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 4.8] [Reference Citation Analysis]
137 Farshid P, Darvishi A, Naguib N, Bazrafshan B, Paul J, Mbalisike E, Vogl TJ. Repetitive chemoembolization of hypovascular liver metastases from the most common primary sites. Future Oncol. 2013;9:419-426. [PMID: 23469977 DOI: 10.2217/fon.12.191] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
138 Shriki JE, Seyal AR, Dighe MK, Yeh MM, Jalikis FG, Andeen NK, Lall C, Bhargava P. CT of Atypical and Uncommon Presentations of Hepatocellular Carcinoma. AJR Am J Roentgenol 2015;205:W411-23. [PMID: 26397348 DOI: 10.2214/AJR.14.14000] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
139 Luo J, Guo RP, Lai EC, Zhang YJ, Lau WY, Chen MS, Shi M. Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study. Ann Surg Oncol. 2011;18:413-420. [PMID: 20839057 DOI: 10.1245/s10434-010-1321-8] [Cited by in Crossref: 205] [Cited by in F6Publishing: 195] [Article Influence: 18.6] [Reference Citation Analysis]
140 Liapi E, Geschwind JF. Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization? Cardiovasc Intervent Radiol. 2011;34:37-49. [PMID: 21069333 DOI: 10.1007/s00270-010-0012-y] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 7.0] [Reference Citation Analysis]
141 Brown DB, Cardella JF, Sacks D, Goldberg SN, Gervais DA, Rajan DK, Vedantham S, Miller DL, Brountzos EN, Grassi CJ, Towbin RB; SIR Standards of Practice Committee, Angle JF, Balter S, Clark TW, Cole PE, Drescher P, Freeman NJ, Georgia JD, Haskal Z, Hovsepian DM, Kilnani NM, Kundu S, Malloy PC, Martin LG, McGraw JK, Meranze SG, Meyers PM, Millward SF, Murphy K, Neithamer CD Jr, Omary RA, Patel NH, Roberts AC, Schwartzberg MS, Siskin GP, Smouse HR, Swan TL, Thorpe PE, Vesely TM, Wagner LK, Wiechmann BN, Bakal CW, Lewis CA, Nemcek AA Jr, Rholl KS. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy. J Vasc Interv Radiol. 2009;20:S219-S226, S226.e1-S226.10. [PMID: 19560002 DOI: 10.1016/j.jvir.2009.04.033] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
142 Mitchell JW, O'Connell WG, Kisza P, Klyde DP, Gonzalez SF, Maldjian P, Bahramipour P, Contractor SG. Safety and feasibility of outpatient transcatheter hepatic arterial embolization for hepatocellular carcinoma. J Vasc Interv Radiol 2009;20:203-8. [PMID: 19097805 DOI: 10.1016/j.jvir.2008.10.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
143 Chuang W, Lin C, Wu D, Shih PM, Liu G. Supraumbilical Skin Rash and Fat Necrosis after Transcatheter Arterial Chemoembolization: A Case Report. The Kaohsiung Journal of Medical Sciences 2004;20:36-9. [DOI: 10.1016/s1607-551x(09)70082-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
144 Kim HC, Chung JW, Lee W, Jae HJ, Park JH. Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics. 2005;25 Suppl 1:S25-S39. [PMID: 16227494 DOI: 10.1148/rg.25si055508] [Cited by in Crossref: 152] [Cited by in F6Publishing: 108] [Article Influence: 10.1] [Reference Citation Analysis]
145 Sawhney S, Montano-Loza AJ, Salat P, McCarthy M, Kneteman N, Meza-Junco J, Owen R. Transarterial chemoembolization in patients with hepatocellular carcinoma: predictors of survival. Can J Gastroenterol 2011;25:426-32. [PMID: 21912767 DOI: 10.1155/2011/864234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
146 Shin SW, Do YS, Choo SW, Lieu WC, Cho SK, Park KB, Yoo BC, Kang EH, Choo I. Diaphragmatic Weakness after Transcatheter Arterial Chemoembolization of Inferior Phrenic Artery for Treatment of Hepatocellular Carcinoma. Radiology 2006;241:581-8. [DOI: 10.1148/radiol.2412051209] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
147 Benzakoun J, Ronot M, Lagadec M, Allaham W, Garcia Alba C, Sibert A, Vilgrain V. Risks factors for severe pain after selective liver transarterial chemoembolization. Liver Int. 2017;37:583-591. [PMID: 27529160 DOI: 10.1111/liv.13235] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
148 Willatt JM, Francis IR, Novelli PM, Vellody R, Pandya A, Krishnamurthy VN. Interventional therapies for hepatocellular carcinoma. Cancer Imaging 2012;12:79-88. [PMID: 22487698 DOI: 10.1102/1470-7330.2012.0011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
149 Miyayama S, Yamashiro M, Okuda M, Yoshie Y, Sugimori N, Igarashi S, Nakashima Y, Matsui O. Hepatocellular Carcinoma Supplied by the Right Lumbar Artery. Cardiovasc Intervent Radiol 2010;33:53-60. [DOI: 10.1007/s00270-009-9595-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
150 Chung JW, Kim HC, Yoon JH, Lee HS, Jae HJ, Lee W, Park JH. Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Radiol. 2006;7:257-266. [PMID: 17143029 DOI: 10.3348/kjr.2006.7.4.257] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
151 Kim JH, Yoon HK, Kim SY, Kim KM, Ko GY, Gwon DI, Sung KB. Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis. Aliment Pharmacol Ther. 2009;29:1291-1298. [PMID: 19392861 DOI: 10.1111/j.1365-2036.2009.04016.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
152 Shin SW. The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol. 2009;10:425-434. [PMID: 19721826 DOI: 10.3348/kjr.2009.10.5.425] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 8.0] [Reference Citation Analysis]
153 Kim JH, Yeon JE, Jong YK, Seo WK, Cha IH, Seo TS, Park JJ, Kim JS, Bak YT, Byun KS. Spinal cord injury subsequent to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. Dig Liver Dis. 2010;42:67-70. [PMID: 19546038 DOI: 10.1016/j.dld.2009.05.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
154 Zheng CS, Feng GS, Zhou RM, Liang B, Liang HM, Zhen J, Yu JM, Liu H. Hepatic arterial infusion chemotherapy and embolization in the treatment of primary hepatic carcinoma. World J Gastroenterol 1997;3:104-7. [PMID: 27041959 DOI: 10.3748/wjg.v3.i2.104] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
155 Liu L, Zhang C, Zhao Y, Qi X, Chen H, Bai W, He C, Guo W, Yin Z, Fan D, Han G. Transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis: prognostic factors in a single-center study of 188 patients. Biomed Res Int. 2014;2014:194278. [PMID: 24800212 DOI: 10.1155/2014/194278] [Cited by in Crossref: 9] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
156 Farrés MT, Baere TD, Lagrange C, Ramirez L, Rougier P, Munck J, Roche A. Percutaneous mitoxantrone injection for primary and secondary liver tumors: Preliminary results. Cardiovasc Intervent Radiol 1998;21:399-403. [DOI: 10.1007/s002709900287] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
157 Brown KT, Nevins AB, Getrajdman GI, Brody LA, Kurtz RC, Fong Y, Blumgart LH. Particle Embolization for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 1998;9:822-8. [DOI: 10.1016/s1051-0443(98)70398-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
158 Kim H, Chung JW, Jae HJ, Lee W, Ho So Y, Park JH. Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization of the Gonadal Artery. Journal of Vascular and Interventional Radiology 2006;17:703-9. [DOI: 10.1097/01.rvi.0000208395.84723.4b] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
159 Park SJ, Kim CH, Kim JD, Um SH, Yim SY, Seo MH, Lee DI, Kang JH, Keum B, Kim YS. Spinal cord injury after conducting transcatheter arterial chemoembolization for costal metastasis of hepatocellular carcinoma. Clin Mol Hepatol. 2012;18:316-320. [PMID: 23091813 DOI: 10.3350/cmh.2012.18.3.316] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
160 Miyayama S, Matsui O, Taki K, Minami T, Ryu Y, Ito C, Nakamura K, Inoue D, Notsumata K, Toya D, Tanaka N, Mitsui T. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol 2006;29:39-48. [PMID: 16328697 DOI: 10.1007/s00270-004-0287-y] [Cited by in Crossref: 102] [Cited by in F6Publishing: 67] [Article Influence: 6.8] [Reference Citation Analysis]
161 Grover I, Ahmad N, Googe AB. Hepatogastric Fistula following Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma. Case Rep Gastroenterol 2014;8:286-90. [PMID: 25408632 DOI: 10.1159/000368302] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
162 Salem R, Thurston KG. Radioembolization with 90Yttrium Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver Malignancies. Journal of Vascular and Interventional Radiology 2006;17:1425-39. [DOI: 10.1097/01.rvi.0000235779.88652.53] [Cited by in Crossref: 151] [Cited by in F6Publishing: 41] [Article Influence: 10.1] [Reference Citation Analysis]
163 Chen MJ, Lin CC, Chang WH, Yang FS. Biloma following repeated transcatheter arterial embolization and complicated by intrahepatic duct stones: a case report. World J Gastroenterol 2005;11:4764-5. [PMID: 16094727 DOI: 10.3748/wjg.v11.i30.4764] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
164 Yamaura K, Higashi M, Akiyoshi K, Itonaga Y, Inoue H, Takahashi S. Pulmonary lipiodol embolism during transcatheter arterial chemoembolization for hepatoblastoma under general anaesthesia: . European Journal of Anaesthesiology 2000;17:704-8. [DOI: 10.1097/00003643-200011000-00009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
165 Ong GY, Changchien CS, Lee CM, Wang JH, Tung HD, Chuah SK, Chiu KW, Chiou SS, Cheng YF, Lu SN. Liver abscess complicating transcatheter arterial embolization: a rare but serious complication. A retrospective study after 3878 procedures. Eur J Gastroenterol Hepatol. 2004;16:737-742. [PMID: 15256974 DOI: 10.1097/01.meg.0000108361.41221.8c] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
166 Tu J, Jia Z, Ying X, Zhang D, Li S, Tian F, Jiang G. The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma. Medicine (Baltimore) 2016;95:e5606. [PMID: 27930585 DOI: 10.1097/MD.0000000000005606] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 7.5] [Reference Citation Analysis]
167 Mason MC, Massarweh NN, Salami A, Sultenfuss MA, Anaya DA. Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma. HPB (Oxford) 2015;17:1137-44. [PMID: 26374137 DOI: 10.1111/hpb.12487] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
168 Mclucas B, Goodwin SC, Perrella R. Embolisation of myomata for pelvic haemorrhage: An alternative to hysterectomy. Minimally Invasive Therapy & Allied Technologies 2009;7:261-5. [DOI: 10.3109/13645709809152861] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
169 Woo S, Chung JW, Hur S, Joo SM, Kim HC, Jae HJ, Park JH. Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: frequency and risk factors. AJR Am J Roentgenol. 2013;200:1370-1377. [PMID: 23701078 DOI: 10.2214/ajr.12.9630] [Cited by in Crossref: 59] [Cited by in F6Publishing: 18] [Article Influence: 7.4] [Reference Citation Analysis]
170 Grozinsky-Glasberg S, Bloom AI, Lev-Cohain N, Klimov A, Besiso H, Gross DJ. The role of hepatic trans-arterial chemoembolization in metastatic medullary thyroid carcinoma: a specialist center experience and review of the literature. Eur J Endocrinol. 2017;176:463-470. [PMID: 28100632 DOI: 10.1530/eje-16-0960] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
171 Osuga K, Anwar Khankan A, Hori S, Okada A, Sugiura T, Maeda M, Nagano H, Yamada A, Murakami T, Nakamura H. Transarterial Embolization for Large Hepatocellular Carcinoma with Use of Superabsorbent Polymer Microspheres: Initial Experience. Journal of Vascular and Interventional Radiology 2002;13:929-34. [DOI: 10.1016/s1051-0443(07)61777-1] [Cited by in Crossref: 43] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
172 Malagari K, Kiakidis T, Pomoni M, Moschouris H, Emmanouil E, Spiridopoulos T, Sotirchos V, Tandeles S, Koundouras D, Kelekis A. Pharmacokinetics, Safety, and Efficacy of Chemoembolization with Doxorubicin-Loaded Tightly Calibrated Small Microspheres in Patients with Hepatocellular Carcinoma. Cardiovasc Intervent Radiol. 2016;39:1379-1391. [PMID: 27393274 DOI: 10.1007/s00270-016-1382-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
173 Kiely JM, Rilling WS, Touzios JG, Hieb RA, Franco J, Saeian K, Quebbeman EJ, Pitt HA. Chemoembolization in Patients at High Risk: Results and Complications. Journal of Vascular and Interventional Radiology 2006;17:47-53. [DOI: 10.1097/01.rvi.0000195074.43474.2f] [Cited by in Crossref: 37] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
174 Malagari K, Pomoni M, Spyridopoulos TN, Moschouris H, Kelekis A, Dourakis S, Alexopoulou E, Koskinas J, Angelopoulos M, Kornezos J, Pomoni A, Tandeles S, Marinis A, Rizos S, Kelekis D. Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients. Cardiovasc Intervent Radiol 2011;34:774-85. [PMID: 21184228 DOI: 10.1007/s00270-010-0044-3] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 8.2] [Reference Citation Analysis]
175 Ibrahim SM, Nikolaidis P, Miller FH, Lewandowski RJ, Ryu RK, Sato KT, Senthilnathan S, Riaz A, Kulik L, Mulcahy MF, Omary RA, Salem R. Radiologic findings following Y90 radioembolization for primary liver malignancies. Abdom Imaging. 2009;34:566-581. [PMID: 18777189 DOI: 10.1007/s00261-008-9454-y] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
176 Gwon DI, Ko G, Yoon H, Sung K, Lee JM, Ryu SJ, Seo MH, Shim J, Lee GJ, Kim HK. Inferior Phrenic Artery: Anatomy, Variations, Pathologic Conditions, and Interventional Management. RadioGraphics 2007;27:687-705. [DOI: 10.1148/rg.273065036] [Cited by in Crossref: 57] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
177 Yoon H, Kim J, Kim K, Lee I, Ko G, Song H, Gwon D. Transcatheter arterial chemo-lipiodol infusion for unresectable hepatocellular carcinoma in 96 high-risk patients. Clinical Radiology 2010;65:271-7. [DOI: 10.1016/j.crad.2010.01.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
178 Kim HC, Lee JH, Chung JW, Kang B, Yoon JH, Kim YJ, Lee HS, Jae HJ, Park JH. Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein. J Vasc Interv Radiol. 2013;24:274-283. [PMID: 23369561 DOI: 10.1016/j.jvir.2012.11.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
179 Chen J, Huang J, Chen M, Yang K, Chen J, Wang J, Xu L, Zhou Z, Zhang Y. Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients. J Cancer 2017;8:2984-91. [PMID: 28928890 DOI: 10.7150/jca.20978] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
180 Kim HC, Chung JW, Park JH, An S, Son KR, Seong NJ, Jae HJ. Transcatheter arterial chemoembolization for hepatocellular carcinoma: prospective assessment of the right inferior phrenic artery with C-arm CT. J Vasc Interv Radiol 2009;20:888-95. [PMID: 19481471 DOI: 10.1016/j.jvir.2009.03.036] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
181 Malagari K. Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead. Expert Rev Anticancer Ther. 2008;8:1643-1650. [PMID: 18925855 DOI: 10.1586/14737140.8.10.1643] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
182 Li J, Chu J, Yang J, Chen W, Wang Y, Huang Y. Preoperative Transcatheter Selective Arterial Chemoembolization in Treatment of Unresectable Hepatoblastoma in Infants and Children. Cardiovasc Intervent Radiol 2008;31:1117-23. [DOI: 10.1007/s00270-008-9373-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
183 Pua U, Merkle EM. Case report. Spontaneous cholecystocolic fistula and locoregional liver tumour ablation: a cautionary tale. Br J Radiol. 2011;84:e243-e245. [PMID: 22101592 DOI: 10.1259/bjr/13919678] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
184 Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, Tibballs J, Meyer T, Patch DW, Burroughs AK. Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol. 2007;30:6-25. [PMID: 17103105 DOI: 10.1007/s00270-006-0062-3] [Cited by in Crossref: 552] [Cited by in F6Publishing: 453] [Article Influence: 39.4] [Reference Citation Analysis]
185 Joskin J, de Baere T, Auperin A, Tselikas L, Guiu B, Farouil G, Boige V, Malka D, Leboulleux S, Ducreux M, Baudin E, Deschamps F. Predisposing Factors of Liver Necrosis after Transcatheter Arterial Chemoembolization in Liver Metastases from Neuroendocrine Tumor. Cardiovasc Intervent Radiol 2015;38:372-80. [DOI: 10.1007/s00270-014-0914-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
186 Buijs M, Vossen JA, Frangakis C, Hong K, Georgiades CS, Chen Y, Liapi E, Geschwind JF. Nonresectable hepatocellular carcinoma: long-term toxicity in patients treated with transarterial chemoembolization--single-center experience. Radiology 2008;249:346-54. [PMID: 18796686 DOI: 10.1148/radiol.2483071902] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 3.7] [Reference Citation Analysis]
187 Kiefer MV, Albert M, Mcnally M, Robertson M, Sun W, Fraker D, Olthoff K, Christians K, Pappas S, Rilling W, Soulen MC. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: A 2-center study. Cancer 2011;117:1498-505. [DOI: 10.1002/cncr.25625] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 8.0] [Reference Citation Analysis]
188 Barzakova ES, Schulze-Hagen M, Zimmermann M, Lurje G, Bednarsch J, Pedersoli F, Isfort P, Kuhl C, Bruners P. Monitoring Liver Function of Patients Undergoing Transarterial Chemoembolization (TACE) by a 13C Breath Test (LiMAx). Cardiovasc Intervent Radiol 2019;42:1702-8. [PMID: 31535181 DOI: 10.1007/s00270-019-02325-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
189 Yoon HM, Kim JH, Kim EJ, Gwon DI, Ko GY, Ko HK. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort. J Vasc Interv Radiol. 2013;24:1639-1646. [PMID: 23962438 DOI: 10.1016/j.jvir.2013.06.017] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
190 Savastano S, Miotto D, Casarrubea G, Teso S, Chiesura-Corona M, Feltrin GP. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child’s grade A or B cirrhosis: a multivariate analysis of prognostic factors. J Clin Gastroenterol. 1999;28:334-340. [PMID: 10372931 DOI: 10.1097/00004836-199906000-00010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 2.4] [Reference Citation Analysis]
191 Thabet A, Kalva S, Gervais DA. Percutaneous image-guided therapy of intra-abdominal malignancy: imaging evaluation of treatment response. Abdom Imaging 2009;34:593-609. [DOI: 10.1007/s00261-008-9448-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
192 Baysal T, D’agostino HB, Serra EE, Valji K, Rose SC, Kinney TB. Supraumbilical Dermal Sclerosis and Fat Necrosis from Chemoembolization of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology 1998;9:645-7. [DOI: 10.1016/s1051-0443(98)70336-7] [Cited by in Crossref: 8] [Article Influence: 0.3] [Reference Citation Analysis]
193 Sangro B, D'avola D, Iñarrairaegui M, Prieto J. Transarterial therapies for hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2011;12:1057-73. [DOI: 10.1517/14656566.2011.545346] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
194 Xing M, Kooby DA, El-Rayes BF, Kokabi N, Camacho JC, Kim HS. Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review. J Surg Oncol. 2014;110:182-196. [PMID: 24760444 DOI: 10.1002/jso.23619] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]